Robert  Haile  to  SEER Program
                            
                            
                                This is a "connection" page, showing publications  Robert  Haile  has written about  SEER Program.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.368
         
        
        
     
 
    
        
        - 
            Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans. Cancer Prev Res (Phila). 2020 09; 13(9):773-782.
            
            
                Score: 0.163
             
- 
            Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. J Natl Cancer Inst. 2017 10 01; 109(10).
            
            
                Score: 0.034
             
- 
            Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012. J Invest Dermatol. 2017 11; 137(11):2282-2290.
            
            
                Score: 0.033
             
- 
            Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017 Jul 19; 19(1):83.
            
            
                Score: 0.033
             
- 
            Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2250-65.
            
            
                Score: 0.028
             
- 
            Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):681-4.
            
            
                Score: 0.023
             
- 
            Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 May 10; 28(14):2404-10.
            
            
                Score: 0.020
             
- 
            Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8.
            
            
                Score: 0.020
             
- 
            Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85.
            
            
                Score: 0.014